Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hatherill

Showing results (211-220 of 222) with videos related to

Pageof 23
Sort By:
Nature Communications|May 7, 2016
Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infantsHelen A Fletcher, Margaret A Snowden, Bernard Landry, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 26, 2022
REL and BHLHE40 Variants Are Associated with IL-12 and IL-10 Responses and Tuberculosis RiskJaveed A Shah, Alex J Warr, Andrew D Graustein, et al.
The Journal of Infectious Diseases|March 27, 2012
Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panelStephen M Graham, Tahmeed Ahmed, Farhana Amanullah, et al.
American Journal of Respiratory and Critical Care Medicine|September 14, 2021
Longitudinal Dynamics of a Blood Transcriptomic Signature of TuberculosisHumphrey Mulenga, Munyaradzi Musvosvi, Simon C Mendelsohn, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
Tongue swab <i>Mycobacterium tuberculosis</i> qPCR for community screening of asymptomatic TB vs. clinic-based triage of symptomatic TBRachel C Wood, Alaina M Olson, Katherine A Lochner, et al.
The Lancet. HIV|October 14, 2022
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panelMaurine D Miner, Mark Hatherill, Vidya Mave, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Inflammatory Biomarkers of Asymptomatic and Symptomatic TuberculosisDenis Awany, Dominique T Ariefdien, Simon C Mendelsohn, et al.
Lancet (London, England)|March 28, 2016
A blood RNA signature for tuberculosis disease risk: a prospective cohort studyDaniel E Zak, Adam Penn-Nicholson, Thomas J Scriba, et al.
Gates Open Research|March 13, 2018
Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trialRay Y Chen, Laura E Via, Lori E Dodd, et al.
American Journal of Respiratory and Critical Care Medicine|April 7, 2018
Four-Gene Pan-African Blood Signature Predicts Progression to TuberculosisSara Suliman, Ethan G Thompson, Jayne Sutherland, et al.
Pageof 23

Showing results (211-220 of 222) with videos related to

Sort By:
Pageof 23
Nature Communications|May 7, 2016
Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infantsHelen A Fletcher, Margaret A Snowden, Bernard Landry, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 26, 2022
REL and BHLHE40 Variants Are Associated with IL-12 and IL-10 Responses and Tuberculosis RiskJaveed A Shah, Alex J Warr, Andrew D Graustein, et al.
The Journal of Infectious Diseases|March 27, 2012
Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panelStephen M Graham, Tahmeed Ahmed, Farhana Amanullah, et al.
American Journal of Respiratory and Critical Care Medicine|September 14, 2021
Longitudinal Dynamics of a Blood Transcriptomic Signature of TuberculosisHumphrey Mulenga, Munyaradzi Musvosvi, Simon C Mendelsohn, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
Tongue swab <i>Mycobacterium tuberculosis</i> qPCR for community screening of asymptomatic TB vs. clinic-based triage of symptomatic TBRachel C Wood, Alaina M Olson, Katherine A Lochner, et al.
The Lancet. HIV|October 14, 2022
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panelMaurine D Miner, Mark Hatherill, Vidya Mave, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Inflammatory Biomarkers of Asymptomatic and Symptomatic TuberculosisDenis Awany, Dominique T Ariefdien, Simon C Mendelsohn, et al.
Lancet (London, England)|March 28, 2016
A blood RNA signature for tuberculosis disease risk: a prospective cohort studyDaniel E Zak, Adam Penn-Nicholson, Thomas J Scriba, et al.
Gates Open Research|March 13, 2018
Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trialRay Y Chen, Laura E Via, Lori E Dodd, et al.
American Journal of Respiratory and Critical Care Medicine|April 7, 2018
Four-Gene Pan-African Blood Signature Predicts Progression to TuberculosisSara Suliman, Ethan G Thompson, Jayne Sutherland, et al.
Pageof 23